Table 2.
Nanoparticle based anti-rheumatic arthritic drugs.
| S. No | Drugs | Nano carrier | Particle size (nm) / Zeta potential (mV) | Therapeutic effects | References |
|---|---|---|---|---|---|
| 1. | MTX | Gold half shell nanoparticle | 100-115/-- | Anti-rheumatic arthritic effect | [46] |
| 2. | Celecoxib | Solid lipid nanoparticle (Tristearin) | 188/+9.12 | Anti-inflammatory, Anti-rheumatic arthritic | [47] |
| 3. | Dexamethasone and MTX | Chitosan Nanoparticles | 299.4/+35.7 | Anti-arthritic, anti-inflammatory and antioxidant potential | [48] |
| 4. | Curcumin | Carboxy methyl cellulose acetate butyrate (CMCAB) | CMCAB172.3/-47.8 PLGA 201.8/ −34.7 |
Anti-rheumatic arthritic effect | [49] |
| 5. | MTX | (Arginine glycine aspartic acid) peptide conjugated gold shell nanoparticle | 100/-11.5 | Anti-inflammatory, anti-rheumatic arthritic effects | [50] |
| 6. | Tacrolimus | Human serum albumin | 185/-30.5 | Anti-rheumatic arthritic effect | [51] |